Sugi Predict

Sugi Predict / Compounds / SCHEMBL74778

SCHEMBL74778

SCHEMBL74778

CC(=O)OC=CCCOC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM5 P08912 2/20 0.43
▸ CHRM1 P11229 2/20 0.43
▸ CHRM3 P20309 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ ALDH1A1 P00352 5/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ PGR P06401 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ TBXA2R P21731 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ CHRNA10 Q9GZZ6 1/20 0.40
▸ CHRNA9 Q9UGM1 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ GALR3 O60755 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7200290 1.00 CHRM5 (0.43) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL74777 1.00 CHRM5 (0.43) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL11058403 0.88 CHRM5 (0.41) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL29801137 0.88 ALDH1A1 (0.48) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL6674430 0.86 ALOX15 (0.40) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL5505267 0.84 ALOX15 (0.44) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL1906626 0.84 ALDH1A1 (0.50) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL19333596 0.84 ALDH1A1 (0.33) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL1906628 0.84 ALDH1A1 (0.50) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL13563053 0.83 ALOX15 (0.43) CHRM5CHRM1CHRM3ALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144767-A1 METHODS FOR STIMULATING CUTANEOUS RECEPTORS IN GLABROUS SKIN OF A PERSON NABOSO TECHNOLOGY INC. (US) 2026-05-28 — — US claimed
US-12478596-B2 Methods for stimulating cutaneous receptors in glabrous skin of a person NABOSO TECHNOLOGY INC. (US) 2025-11-25 — — US claimed
WO-2024186647-A1 METHODS FOR CONVERTING POLYVINYL CHLORIDE TO SMALLER MOLECULES USING OLEFIN CROSS METATHESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-09-12 — — WO claimed
US-20230355471-A1 SOMATOSENSATION AND PROPRIOCEPTOR STIMULATION SURFACE NABOSO TECHNOLOGY INC. 2023-11-09 — — US claimed
US-11642279-B2 Somatosensation and proprioceptor stimulation surface NABOSO TECHNOLOGY INC. (US) 2023-05-09 — — US claimed
CN-114100689-A Hydrogenation catalyst, preparation method and application thereof 万华化学集团股份有限公司 2022-03-01 — — CN claimed
CN-112457156-A Reinforcing system and process for preparing 1, 4-butanediol from butadiene and acetic acid 南京延长反应技术研究院有限公司 2021-03-09 — — CN claimed
US-20210000686-A1 Somatosensation and Proprioceptor Stimulation Surface NABOSO TECHNOLOGY INC. 2021-01-07 — — US claimed
CN-107915579-B Method for synthesizing 1,4-butanediol from butadiene 中国石油化工股份有限公司 2020-06-09 — — CN claimed
CN-107774252-B Hydrogenation catalyst for producing 1, 4-diacetoxybutane 中国石油化工股份有限公司 2020-04-17 — — CN claimed
US-4228301-A BY CATALYTIC OXIDATION OF BUTADIENE REACTED WITH ACETIC ACID JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1980-10-14 — — US claimed
US-4225729-A Process for hydrogenation of diacetoxybutene MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1980-09-30 — — US claimed
US-4152525-A ABSORPTION IN ACETIC ACID, RECYCLING, HYDROLYSIS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1979-05-01 — — US claimed
US-4121039-A REACTING CONJUGATED DIENE WITH OXYGEN, CATALYST SELECTIVITY GAF CORPORATION (US) 1978-10-17 — — US claimed
US-4093633-A DEHYDROCYCLIZATION OF 1,4-BUTANEDIOL, ACID CATALYST MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-06-06 — — US claimed
US-4075413-A PALLADIUM CATALYST MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-02-21 — — US claimed
US-4062900-A OR BUTENEDIOLHYDROLYZING DIACETOXY-BUTANE OR BUTENE MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1977-12-13 — — US claimed
US-4057472-A FRACTIONAL DISTILLATION Haji, Noboru (JA) 1977-11-08 — — US claimed
US-4010197-A Process for producing diacetoxybutanes and butanediols MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-03-01 — — US claimed
US-3952071-A ALUMINUM HALIDE-POLYHYDRIC ALCOHOL DERIVATIVE CATALYST LION FAT & OIL CO., LTD. (JA) 1976-04-20 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144767-A1 METHODS FOR STIMULATING CUTANEOUS RECEPTORS IN GLABROUS SKIN OF A PERSON PIEZO1, MC1R, SSTR1 CHRM5 1763/4885CHRM1 1835/4885CHRM3 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.